The Medical Establishment Begins Its Retreat on Mutilating Children

The medical establishment’s house of cards is finally collapsing. The American Society of Plastic Surgeons became the first major U.S. medical organization to withdraw support for gender-related surgeries on minors this week, delivering a devastating blow to the trans industry that has profited from mutilating children.

The organization, which represents more than 11,000 physicians worldwide, published a position statement Tuesday that amounts to a stunning admission: doctors rushed headlong into experimental treatments on minors without adequate evidence. The statement acknowledges that “clinical practice progressed amid growing patient demand” but notes that international reviews have exposed “growing uncertainty about the benefits of medical and surgical interventions.”

Translation: They got it wrong, and kids paid the price.

After examining evidence reviews, ASPS found what critics have warned about for years—poor study quality, inconsistent results, short follow-up periods, and mounting evidence of complications and harm. The organization finally admitted there is insufficient evidence to demonstrate a favorable risk-benefit ratio for gender-related treatments in young people.

The society now recommends delaying all irreversible gender-related surgeries—including breast, chest, genital, and facial procedures—until patients reach at least 19 years old. Surgeons should no longer treat prior medical interventions, referrals, or support letters as proof of surgical readiness. It’s a remarkable reversal that exposes how recklessly the medical community has operated.

ASPS emphasized that these surgeries permanently destroy sexual function, fertility, and healthy bodies while interfering with “identity formation and psychosexual development.” Perhaps most damning, the organization acknowledged that a “substantial proportion of children with prepubertal onset gender dysphoria experience resolution or significant reduction of distress by the time they reach adulthood, absent medical or surgical intervention.”

In other words, most kids would have been fine if doctors had simply left them alone.

The policy shift draws on the United Kingdom’s Cass Review and a 2025 Department of Health and Human Services report—both scathing indictments of the gender industry. The Cass Review recommended abandoning the affirmative care model that rubber-stamped puberty blockers and hormones in favor of actual psychological support. The HHS report found that the “rapid expansion and implementation of a clinical protocol” for pediatric transgender medicine “lacked sufficient scientific and ethical justification.”

“We commend the American Society of Plastic Surgeons for standing up to the overmedicalization lobby and defending sound science,” Health and Human Services Secretary Robert F. Kennedy, Jr. said. “By taking this stand, they are helping protect future generations of American children from irreversible harm.”

The announcement comes as detransitioners are finally getting their day in court. Last month, a Westchester County jury awarded Fox Varian $2 million after she sued the psychologist and surgeon who fast-tracked her toward a double mastectomy at 16. Psychologist Kenneth Einhorn buried crucial mental health details, while surgeon Simon Chin spent barely an hour with her across two appointments before removing her breasts. Both admitted they failed to meet basic care standards—yet they proceeded anyway.

The case marked the first malpractice lawsuit by a detransitioner to reach trial and secure a favorable verdict. It won’t be the last. Twenty-eight detransitioner lawsuits are reportedly moving through courts nationwide, while at least 27 states have enacted laws protecting children from these barbaric procedures.

The tide is turning. The question now is how many more children will be sacrificed before the rest of the medical establishment follows suit.